These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19242353

  • 1. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system.
    Kielstein JT, Hesse G, Bahr MJ, Tsikas D, Terkamp C, Martens-Lobenhoffer J, Manns MP, Haller H, Panning B, Bode-Böger SM, Gebel M.
    Crit Care Med; 2009 Apr; 37(4):1483-5. PubMed ID: 19242353
    [Abstract] [Full Text] [Related]

  • 2. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
    Castroagudín JF, Delgado M, Villanueva A, Bustamante M, Martínez J, Otero E, Tomé S, Martínez SM, Segade FR, Conde R, Dominguez-Muñoz E, Varo E.
    Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568
    [Abstract] [Full Text] [Related]

  • 3. Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ferlitsch A, Kreil A, Bauer E, Schmidinger H, Schillinger M, Gangl A, Peck-Radosavljevic M.
    Eur J Clin Invest; 2004 Mar; 34(3):218-23. PubMed ID: 15025681
    [Abstract] [Full Text] [Related]

  • 4. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K, Masaki T, Watanabe S, Nakai S, Deguchi A, Morishita A, Yoneyama H, Ohgi T, Ono M, Yoshitake A, Kako T, Ohmachi N, Kiuchi T, Maeta T, Yoshida M, Mori Y, Kohi F, Kuriyama S.
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [Abstract] [Full Text] [Related]

  • 5. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH, Bruners P, Günther RW.
    Dig Dis; 2009 Apr; 27(2):148-56. PubMed ID: 19546553
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ohmoto K, Kunieda T, Shibata N, Yamamoto S.
    Hepatogastroenterology; 2000 Apr; 47(35):1199-202. PubMed ID: 11100310
    [Abstract] [Full Text] [Related]

  • 7. Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection.
    Nimmaanrat S, Prechawai C, Tanomkiat W.
    Minerva Anestesiol; 2007 Jun; 73(6):333-7. PubMed ID: 17589422
    [Abstract] [Full Text] [Related]

  • 8. Changes of AFPmRNA in blood after percutaneous ethanol injection treatment of hepatocellular carcinoma.
    Liu Y, Wu MC, Qian GX, Zhang BH.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):243-5. PubMed ID: 14612276
    [Abstract] [Full Text] [Related]

  • 9. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report.
    Okada S, Aoki K, Okazaki N, Nose H, Yoshimori M, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S.
    Hepatogastroenterology; 1993 Oct; 40(5):496-8. PubMed ID: 8270243
    [Abstract] [Full Text] [Related]

  • 10. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy.
    Fukuda H, Ebara M, Okabe S, Yoshikawa M, Sugiura N, Saisho H, Kondo F, Yukawa M.
    J Lab Clin Med; 2004 Jun; 143(6):333-9. PubMed ID: 15192648
    [Abstract] [Full Text] [Related]

  • 11. Atropine for prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: a randomized, placebo-controlled, double-blind trial.
    Arnulf F, Monika S, Herwig S, Monika H, Johannes PD, Gregor U, Alfred G, Markus PR.
    Liver Int; 2009 May; 29(5):715-20. PubMed ID: 19018977
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous coagulation therapy of hepatocellular carcinoma by combining microwave coagulation therapy and ethanol injection.
    Zhou P, Liu X, Li R, Nie W.
    Eur J Radiol; 2009 Aug; 71(2):338-42. PubMed ID: 18495403
    [Abstract] [Full Text] [Related]

  • 13. Local injection therapy for hepatocellular carcinoma.
    Lin XD, Lin LW.
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):16-21. PubMed ID: 16481276
    [Abstract] [Full Text] [Related]

  • 14. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR, Morris SM, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP.
    Am J Respir Crit Care Med; 2003 Jul 01; 168(1):63-9. PubMed ID: 12626350
    [Abstract] [Full Text] [Related]

  • 15. [Single-session alcohol administration for hepatocarcinoma].
    Livraghi T.
    Radiol Med; 1997 Jul 01; 94(1-2):14-8. PubMed ID: 9424644
    [Abstract] [Full Text] [Related]

  • 16. [A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy].
    Yoon I, Yim HJ, Kim JN, Park SM, Kim JH, Lee SH, Chung HH, Lee HS, Lee SW, Choi JH.
    Korean J Hepatol; 2009 Mar 01; 15(1):90-5. PubMed ID: 19346790
    [Abstract] [Full Text] [Related]

  • 17. Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy.
    Petsas T, Kalogeropoulou C, Tsota I, Tsamandas AC.
    Liver Int; 2006 Apr 01; 26(3):382-4. PubMed ID: 16584403
    [No Abstract] [Full Text] [Related]

  • 18. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.
    Kiettisanpipop P, Lertsapcharorn P, Chotivittayatarakorn P, Poovorawan Y.
    J Med Assoc Thai; 2007 Oct 01; 90(10):2053-7. PubMed ID: 18041423
    [Abstract] [Full Text] [Related]

  • 19. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH.
    Curr Opin Clin Nutr Metab Care; 2008 Jan 01; 11(1):55-61. PubMed ID: 18090660
    [Abstract] [Full Text] [Related]

  • 20. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
    Cheng PN, Leung YC, Lo WH, Tsui SM, Lam KC.
    Cancer Lett; 2005 Jun 16; 224(1):67-80. PubMed ID: 15911102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.